JP2004518639A5 - - Google Patents

Download PDF

Info

Publication number
JP2004518639A5
JP2004518639A5 JP2002544012A JP2002544012A JP2004518639A5 JP 2004518639 A5 JP2004518639 A5 JP 2004518639A5 JP 2002544012 A JP2002544012 A JP 2002544012A JP 2002544012 A JP2002544012 A JP 2002544012A JP 2004518639 A5 JP2004518639 A5 JP 2004518639A5
Authority
JP
Japan
Prior art keywords
alkyl
linear
branched
group
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002544012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004518639A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/043664 external-priority patent/WO2002041831A2/en
Publication of JP2004518639A publication Critical patent/JP2004518639A/ja
Publication of JP2004518639A5 publication Critical patent/JP2004518639A5/ja
Pending legal-status Critical Current

Links

JP2002544012A 2000-11-21 2001-11-21 塩化物分泌を増加しそして炎症を阻害するためのイノシトール誘導体 Pending JP2004518639A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25260300P 2000-11-21 2000-11-21
PCT/US2001/043664 WO2002041831A2 (en) 2000-11-21 2001-11-21 Inositol derivatives for increasing chloride secretion and inhibiting inflammation

Publications (2)

Publication Number Publication Date
JP2004518639A JP2004518639A (ja) 2004-06-24
JP2004518639A5 true JP2004518639A5 (https=) 2005-12-22

Family

ID=22956721

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002544012A Pending JP2004518639A (ja) 2000-11-21 2001-11-21 塩化物分泌を増加しそして炎症を阻害するためのイノシトール誘導体

Country Status (6)

Country Link
US (1) US7453006B2 (https=)
EP (1) EP1345950A4 (https=)
JP (1) JP2004518639A (https=)
AU (1) AU2002217808A1 (https=)
CA (1) CA2430190A1 (https=)
WO (1) WO2002041831A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
WO2003024189A2 (en) * 2001-09-20 2003-03-27 Inologic, Inc. Method of modulating sodium ion absorption in epithelial cells
US7084115B2 (en) 2002-04-29 2006-08-01 Oxyplus, Inc. Inositol pyrophosphates, and methods of use thereof
JPWO2004075906A1 (ja) * 2003-02-26 2006-06-01 リジェンティス株式会社 抗炎症剤及び抗炎症性医療材料
US20060258626A1 (en) * 2004-07-06 2006-11-16 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US20060106000A1 (en) * 2004-07-06 2006-05-18 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US7745423B2 (en) * 2004-07-06 2010-06-29 NormOxys, Inc Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
WO2006102060A1 (en) * 2005-03-18 2006-09-28 Oxyplus, Inc. Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
CN101505763A (zh) * 2006-06-09 2009-08-12 鹿特丹伊拉斯姆斯大学医疗中心 通过肌醇磷脂调节免疫系统
CN101784193A (zh) * 2007-05-01 2010-07-21 诺尔姆奥克西斯公司 促红细胞生成素互补或替代
US8414533B2 (en) 2009-10-08 2013-04-09 Shl Group Ab Medicament delivery device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605063D0 (sv) * 1986-11-26 1986-11-26 Matti Siren Derivatives of cyclohexane
FR2694936B1 (fr) * 1992-08-18 1994-11-25 Bayer Pharma Dérivés substitués du désoxy-myoinositol, procédé pour leur préparation et leur utilisation dans des médicaments.
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
AU721150B2 (en) * 1996-09-20 2000-06-22 Inologic, Inc. Inositol polyphosphate derivatives and methods of using same
US5977078A (en) * 1996-09-20 1999-11-02 The Regents Of The Univesity Of California Inositol polyphosphate derivatives and methods of using same
US6221856B1 (en) * 1999-02-03 2001-04-24 Inologic, Inc. Inositol derivatives for inhibiting superoxide anion production

Similar Documents

Publication Publication Date Title
RU2382026C2 (ru) Аналоги липоксина а4
RU2000132188A (ru) Производные эпотилонов, их синтез и применение
CA2334342A1 (en) Epothilone derivatives and their synthesis and use
JP2004518639A5 (https=)
GB9900334D0 (en) Tricylic vascular damaging agents
RU2008106058A (ru) Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона
HU9300274D0 (en) Phosphonoxical as well as carbonatic derivatives of taxole and medical preparatives containing said active substance
NO20091344L (no) Pleuromutilin-derivater, fremgangsmate for fremstilling av disse, farmasoytisk preparat inneholdende disse, disse forbindelsene for anvendelse i terapi samt anvendelse av disse for fremstilling av medikamenter for behandling av sykdom
JP2005504011A5 (https=)
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
KR880006193A (ko) 피페리딘 화합물 및 그의 제조 및 용도
RU96121572A (ru) Сульфонимидамиды, способ их получения, фармацевтический состав, способ его получения, способ лечения
EP0533825A1 (en) COVALENT CONJUGATES OF ETHER-NUCLEOSIDE LIPIDS.
DE50108674D1 (de) Verbindungen mit einer sulfonamidgruppe und diese verbindungen enthaltende pharmazeutische zusammensetzungen
KR960004345A (ko) 2-(2- 아미노-1,6- 디하이드로-6- 옥소-퓨린-9-일)메톡시-1,3- 프로판 디올 유도체
DE60044369D1 (de) Synthetisches oligomannosid, seine herstellung und verwendung
DE69528291D1 (de) Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung
JP2004502732A5 (https=)
ATE257704T1 (de) Pharmazeutische zusammensetzungen enthaltend norastemizol.
MY106300A (en) Prostaglandin analoques for use in medicine
RU2003134629A (ru) Соединения цефема
RU96123227A (ru) Амидные производные и их терапевтическое использование
JP2006504673A5 (https=)
IT1196041B (it) Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti
JP2003509494A5 (https=)